|
Name |
1H-Cyclopropa[a]naphthalene, 1a,2,3,5,6,7,7a,7b-octahydro-1,1,7,7a-tetramethyl-, (1aR,7R,7aR,7bS)-(+)-
|
Molecular Formula | C15H24 | |
IUPAC Name* |
(7S,7aS)-1,1,7,7a-tetramethyl-2,3,5,6,7,7b-hexahydro-1aH-cyclopropa[a]naphthalene
|
|
SMILES |
C[C@H]1CCC=C2[C@@]1(C3C(C3(C)C)CC2)C
|
|
InChI |
InChI=1S/C15H24/c1-10-6-5-7-11-8-9-12-13(14(12,2)3)15(10,11)4/h7,10,12-13H,5-6,8-9H2,1-4H3/t10-,12?,13?,15+/m0/s1
|
|
InChIKey |
MBIPADCEHSKJDQ-LAKVINJISA-N
|
|
Synonyms |
1H-Cyclopropa[a]naphthalene, 1a,2,3,5,6,7,7a,7b-octahydro-1,1,7,7a-tetramethyl-, (1aR,7R,7aR,7bS)-(+)-; .beta.-Gurjunene; 1H-Cyclopropa[a]naphthalene, 1a,2,3,5,6,7,7a,7b-octahydro-1,1,7,7a-tetramethyl-, [1aR-(1a.alpha.,7.alpha.,7a.alpha.,7b.alpha.)]-; .delta.1(10)-Aristolene; .delta.-Aristol-1(10)-ene; 1(10)-Aristolene, (+)-; (+)-.delta.1(10)-Aristolene; (1aR,7R,7aR,7bS)-1,1,7,7a-Tetramethyl-1a,2,3,5,6,7,7a,7b-octahydro-1H-cyclopropa[a]naphthalene; (7S,7aS)-1,1,7,7a-tetramethyl-2,3,5,6,7,7b-hexahydro-1aH-cyclopropa[a]naphthalene
|
|
CAS | NA | |
PubChem CID | 6432176 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 4.7 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 15 | QED Weighted: | 0.491 |
Caco-2 Permeability: | -4.444 | MDCK Permeability: | 0.00001920 |
Pgp-inhibitor: | 0.292 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.849 |
30% Bioavailability (F30%): | 0.151 |
Blood-Brain-Barrier Penetration (BBB): | 0.414 | Plasma Protein Binding (PPB): | 94.29% |
Volume Distribution (VD): | 2.884 | Fu: | 6.04% |
CYP1A2-inhibitor: | 0.527 | CYP1A2-substrate: | 0.41 |
CYP2C19-inhibitor: | 0.491 | CYP2C19-substrate: | 0.906 |
CYP2C9-inhibitor: | 0.508 | CYP2C9-substrate: | 0.573 |
CYP2D6-inhibitor: | 0.061 | CYP2D6-substrate: | 0.563 |
CYP3A4-inhibitor: | 0.505 | CYP3A4-substrate: | 0.327 |
Clearance (CL): | 15.443 | Half-life (T1/2): | 0.036 |
hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.244 |
Drug-inuced Liver Injury (DILI): | 0.095 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.24 | Maximum Recommended Daily Dose: | 0.774 |
Skin Sensitization: | 0.153 | Carcinogencity: | 0.305 |
Eye Corrosion: | 0.803 | Eye Irritation: | 0.457 |
Respiratory Toxicity: | 0.961 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001183 | 0.673 | D0L2LS | 0.293 | ||||
ENC000949 | 0.474 | D0Z1XD | 0.291 | ||||
ENC001924 | 0.439 | D0K0EK | 0.282 | ||||
ENC001832 | 0.439 | D0D2TN | 0.281 | ||||
ENC001831 | 0.390 | D0V8HA | 0.281 | ||||
ENC003215 | 0.367 | D0C7JF | 0.272 | ||||
ENC002652 | 0.367 | D06XMU | 0.266 | ||||
ENC003477 | 0.355 | D07BSQ | 0.265 | ||||
ENC002256 | 0.355 | D0G8BV | 0.265 | ||||
ENC003095 | 0.349 | D07DVK | 0.261 |